Rohto Pharma India launches Mentholatum Acnes and Oxy Men Skin Care Range nationally

Company Brief

New Delhi, July 18, 2011

Rohto Pharma (India) Pvt. Ltd., Japan’s Leading Consumer Health & Skin Care company and subsidiary of Rohto Pharmaceutical Co., Ltd., Osaka, Japan today unveiled two new skin care products – Mentholatum Acnes, an anti acne formulation (for girls/teenagers) and three variants of Oxy range of face wash for Men.

Rohto Pharmaceutical Co. Ltd. is a leading global Healthcare Company and one of the largest OTC (over-the-counter) pharmaceutical companies in Japan. Rohto Pharma (India) Pvt. Ltd. specialises in a wide range of products in the Consumer Healthcare business domain. The company represents ROHTO and Mentholatum in the region.

Mentholatum Acnes, Japan’s No. 1 Acne care brand, which comes with special formulation for youngsters/ teenagers who suffer from acne problem. Mentholatum Acnes with three steps regime – cleanses, prevents & cures ensures a complete solution to acne problem.

Successfully selling across 40 Countries in the World, Oxy is complete men’s skin care range available in three variants - Oxy Perfect Wash for oily skin, Oxy Active Wash for Young Men with dry skin, and Oxy Deep Wash for Men who are over exposed to sun, pollution and therefore have tanned skin.

As part of the initiatives to launch the new products in India, Converge Integrated Media Solutions Pvt. Ltd. (Converge.I) will be undertaking the branding activities encompassing the entire gamut of ATL/ BTL space, retail & merchandising and driving the overall strategy for the brand. Converge.I will not only drive innovative branding for ROHTO’s new products, but will also be the creative force behind the look and feel of its campaign.

While announcing the launch, Mr. Shingo Kuriyama, MD, Rohto Pharma (India) Pvt. Ltd., said: “The fast growing men’s skincare segment in India, which has experienced more than 40% growth last year, is also expected to see sustained growth trend owing to the increasing awareness among men towards beauty/Grooming. We have the right mix of products of global standards meeting the aspirations of the conscious consumers and we are confident of the role we can play in the growth of this segment.”

“We see Converge.I playing a vital role in our go-to-market strategy with optimum customer outreach tools, implementing right mix of branding and media initiatives that will help us in establishing a strong positioning for the two brands.” He added.

Akash Verma, CEO & Executive Director Converge.I commented, "Rohto Pharmaceutical Co., Ltd. is one of the most well-established brand in the healthcare sector in Japan and is all set to establish a strong foothold in the Indian market. We are glad at the opportunity of contributing to their growth plans and are particularly excited about scripting the identity of the brand."

For further information, please contact:

Mavcomm Consulting Pvt. Ltd.

Akhil Malviya

Mobile: +919313188151

Email: akhil@mavcommgroup.com